Natural course of hypogonadism diagnosed during hospitalization in aged male patients
- 126 Downloads
Our aim was to assess short-term natural course of hypogonadism diagnosed during hospitalization for acute disease in aged male patients after discharge. A group of 43 hypogonadal males, aged 86.7 ± 5.7 year, was studied. Serum concentrations of testosterone (T) and gonadotropins (follicle-stimulating hormone, FSH, and luteinizing hormone, LH) were measured in every patient both at admission and one month after discharge. Mean serum T at entry was 115.4 ± 48.0 ng/dl. Hypogonadism was hyper-, hypo-, and normogonadotropic in 20 (46.5 %), 20 (46.5 %), and 3 (7.0 %) patients, respectively. One month after discharge serum T concentrations increased significantly (230.9 ± 135.6 ng/dl, p < 0.001). At this point, more than half of the patients (n = 27, 62.8 %) showed normal serum T concentrations. Both gonadotropins, FSH (p < 0.001), and LH (p = 0.04) also increased one month after discharge. Approximately, half of the patients (13, 48.1 %) who normalized serum T concentrations also showed normal serum gonadotropin concentrations. Patients who normalized their serum T concentrations one month after discharge showed significantly higher baseline values of T (134.7 ± 33.9 ng/dl) than those who persisted with hypogonadism (n = 16, 32.7 %; 82.8 ± 51.6 ng/dl, p < 0.001). Lastly, serum T was the only independent predictor for achieving eugonadal status (OR 1.030; CI 95 %, 1.010–1.050; p < 0.001). In conclusion, about 63 % of aged patients hospitalized for acute illness with hypogonadism discovered during hospitalization spontaneously normalize their serum T concentrations one month after discharge. Serum gonadotropin concentrations also increased after discharge. Serum T levels at admission was an independent predictor for the normalization of serum T concentrations.
KeywordsTestosterone Elderly Hypogonadism Gonadotropins Spontaneous recovery
This study was funded by the Junta de Castilla y León (Spain), Consejería de Sanidad Proyectos de Investigación en Biomedicina, Biotecnología y Ciencias de la Salud. Expediente nº GRS 393/A/09.
Conflict of interest
- 4.S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, M.R. Blackman, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 86, 724–731 (2001)CrossRefPubMedGoogle Scholar
- 7.A.B. Araujo, A.B. O’Donnell, D.J. Brambilla, W.B. Simpson, C. Longcope, A.M. Matsumoto, J.B. McKinlay, Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 89, 5920–5926 (2004)CrossRefPubMedGoogle Scholar
- 9.C. Wang, E. Nieschlag, R. Swerdloff, H.M. Behre, W.J. Hellstrom, L.J. Gooren, J.M. Kaufman, J.J. Legros, B. Lunenfeld, A. Morales, J.E. Morley, C. Schulman, I.M. Thompson, W. Weidner, F.C. Wu, Investigation, treatment and monitoring of late-onset hypogonadism in males: iSA, ISSAM, EAU, EAA and ASA recommendations. Eur. J. Endocrinol. 159, 507–514 (2008)CrossRefPubMedCentralPubMedGoogle Scholar
- 10.F.C. Wu, A. Tajar, S.R. Pye, A.J. Silman, J.D. Finn, T.W. O’Neill, G. Bartfai, F. Casanueva, G. Forti, A. Giwercman, I.T. Huhtaniemi, K. Kula, M. Punab, S. Boonen, D. Vanderschueren, European Male Aging Study Group, Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study. J. Clin. Endocrinol. Metab. 93, 2737–2745 (2008)CrossRefPubMedGoogle Scholar
- 28.T. Yasui, J. Tomita, Y. Miyatani, M. Yamada, H. Uemura, M. Irahara, M. Arai, N. Kojimahara, R. Okabe, Y. Ishii, S. Tashiro, H. Sato, Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations. Clin. Chim. Acta 386, 69–75 (2007)CrossRefPubMedGoogle Scholar